1Paediatric Endocrinology, Southampton University Hospitals NHS Trust, Southampton, UK
2Paediatric Oncology, Southampton University Hospitals NHS Trust, Southampton, UK
3Paediatric Neurology, Southampton University Hospitals NHS Trust, Southampton, UK
4Paediatric Radiology, Southampton University Hospitals NHS Trust, Southampton, UK
Corresponding author: Dr. J.H. Davies, Consultant in Paediatric Endocrinology, Child Health Directorate, MP 43, Southampton University Hospital Trust, Tremona Road, Southampton SO16 6YD, UK Phone: +44 2380 796985, Fax: +44 2380 795230
Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 24, Issue 9-10, Pages 811–814, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: 10.1515/JPEM.2011.298, August 2011
Abstract
Diabetes insipidus (DI) is rare in childhood and has a wide-ranging aetiology including the involvement of uncontrolled proliferation of dendritic cells in the hypothalamic-pituitary axis, characteristic of Langerhans cell histiocytosis (LCH). DI may manifest as a sequela of multisystem LCH disease involving skin, bone, liver, spleen and lymph nodes. In very rare cases patients diagnosed with LCH exhibit neurodegenerative changes, such as severe ataxia, tremor, dysarthria and intellectual impairment. We report a 2½-year-old boy who presented initially with apparent idiopathic DI, developed anterior pituitary hormone deficiency and progressive neurological deterioration secondary to neurodegenerative LCH.
Comments (0)